NCT05762900: Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
- State
- Under way
- Phase
- Phase 2
- People
- 65 planned
- Started
- 25 Oct 2022
- Primary completion
- 25 Oct 2025
- Arms
- Ultra-hypofractionated arm
- Results
- None posted
- 25 Oct 2022: Trial started
- 10 Mar 2023: Trial registered